Barr Sued By Celgene Over Generic Thalomid
Generic drug maker Barr Pharmaceuticals Inc. has triggered a patent infringement lawsuit from Celgene Corp., a New Jersey drug maker that says Barr trampled the intellectual property rights for its leading...To view the full article, register now.
Already a subscriber? Click here to view full article